Total Payments
$1,313
2023 Payments
$43.89
Companies
15
Transactions
65
Payment Breakdown by Category
Food & Beverage$1,163 (88.6%)
Consulting$150.00 (11.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,163 | 64 | 88.6% |
| Consulting Fee | $150.00 | 1 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ironshore Pharmaceuticals Inc. | $309.14 | 10 | $0 (2023) |
| COMSORT, Inc | $150.00 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $145.67 | 8 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $136.32 | 7 | $0 (2023) |
| Shire North American Group Inc | $116.86 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $100.04 | 7 | $0 (2022) |
| Corium, LLC | $90.22 | 4 | $0 (2022) |
| Sobi, Inc | $57.06 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $51.93 | 5 | $0 (2022) |
| Neos Therapeutics, LP | $49.46 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $43.89 | 3 | Ironshore Pharmaceuticals Inc. ($17.81) |
| 2022 | $135.28 | 8 | Corium, LLC ($46.25) |
| 2021 | $272.16 | 14 | Supernus Pharmaceuticals, Inc. ($109.98) |
| 2020 | $118.02 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($56.68) |
| 2019 | $479.34 | 15 | Ironshore Pharmaceuticals Inc. ($210.34) |
| 2018 | $153.71 | 11 | Shire North American Group Inc ($52.89) |
| 2017 | $110.94 | 9 | Shire North American Group Inc ($35.19) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: PSYCHOLOGY | ||||||
| 02/16/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 01/04/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: EPILEPSY | ||||||
| 12/07/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 11/18/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: PSYCHOLOGY | ||||||
| 11/15/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 11/03/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: VACCINES | ||||||
| 10/25/2022 | Sobi, Inc | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/31/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, VAQTA | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: VACCINE | ||||||
| 03/16/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/09/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.44 | General |
| Category: PSYCHOLOGY | ||||||
| 12/08/2021 | Corium, Inc. | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/29/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: PSYCHOLOGY | ||||||
| 09/30/2021 | Sobi, Inc | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, VAQTA | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: VACCINE | ||||||
| 09/14/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: PSYCHOLOGY | ||||||
| 09/01/2021 | Corium, Inc. | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/03/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: PSYCHOLOGY | ||||||
| 05/21/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: PSYCHOLOGY | ||||||
| 05/06/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. David Schell, MD
Dr. David Schell, MD is a Pediatrics healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649266271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Schell, MD has received a total of $1,313 in payments from pharmaceutical and medical device companies, with $43.89 received in 2023. These payments were reported across 65 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,163).
Ad
Practice Information
- Specialty Pediatrics
- Location Paducah, KY
- Active Since 09/20/2005
- Last Updated 12/02/2020
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649266271
Products in Payments
- VYVANSE (Drug) $233.67
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $210.34
- GARDASIL (Biological) $150.00
- QELBREE (Drug) $136.32
- JORNAY PM (Drug) $98.80
- BEXSERO (Biological) $58.81
- Adzenys XR-ODT (Drug) $49.46
- AZSTARYS (Drug) $46.25
- Azstarys (Drug) $43.97
- PEDIARIX (Biological) $41.23
- MENACTRA (Drug) $39.51
- GARDASIL 9 (Biological) $35.55
- QUILLICHEW ER (Drug) $32.30
- SYNAGIS (Drug) $30.50
- MYDAYIS (Drug) $28.86
- Synagis (Drug) $26.56
- ROTATEQ (Biological) $16.38
- VALTOCO (Drug) $13.18
- SYNAGIS (Biological) $10.95
- Evekeo (Drug) $10.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Paducah
John Cecil, M.d, M.D
Pediatrics — Payments: $26,871
Pediatrics $26,871
Cynthia Bowman-Stroud, M.d, M.D
Pediatrics — Payments: $7,670
Pediatrics $7,670
Caitlyn Cecil, M.d, M.D
Pediatrics — Payments: $4,259
Pediatrics $4,259
Dr. John Roach, M.d, M.D
Pediatrics — Payments: $2,890
Pediatrics $2,890
Jeffrey Mudd, Md, MD
Pediatrics — Payments: $1,971
Pediatrics $1,971
Dr. Rachel Lowdenback, D.o, D.O
Pediatrics — Payments: $1,715
Pediatrics $1,715